Global Portfolio of Antimalarial Medicines, 2QResearch Development Translational Preclinical Preclinical Lead optimisation Phase I Human volunteers Phase IIa Patient exploratory Access Phase IIb/III Registration Patient confirmatory Under review * Oxaboroles 1 Project P218 MMV048 OZ439/PQP Tafenoquine Rectal Artesunate Anacor Novartis BIOTEC UCT/TIA Sanofi GSK CIPLA/Strides/TDR DHODH 3 Projects SJ733 ACT840 OZ439/FQ UTSW/UW/Monash GSK St Jude/Eisai Actelion Sanofi Open Source Drug Discovery Sydney Orthologue Leads Sanofi DDD498 Merck Serono (Dundee) Amino-alcohols Tetraoxanes PA92 Merck Serono LSTM/Liverpool (Drexel/UW/GNF) Imidazolidinediones WRAIR dUTPase inhibitors Medivir Pf. | slideum.com

Global Portfolio of Antimalarial Medicines, 2QResearch Development Translational Preclinical Preclinical Lead optimisation Phase I Human volunteers Phase IIa Patient exploratory Access Phase IIb/III Registration Patient confirmatory Under review * Oxaboroles 1 Project P218 MMV048 OZ439/PQP Tafenoquine Rectal Artesunate Anacor Novartis BIOTEC UCT/TIA Sanofi GSK CIPLA/Strides/TDR DHODH 3 Projects SJ733 ACT840 OZ439/FQ UTSW/UW/Monash GSK St Jude/Eisai Actelion Sanofi Open Source Drug Discovery Sydney Orthologue Leads Sanofi DDD498 Merck Serono (Dundee) Amino-alcohols Tetraoxanes PA92 Merck Serono LSTM/Liverpool (Drexel/UW/GNF) Imidazolidinediones WRAIR dUTPase inhibitors Medivir Pf.

Download Report

Transcript Global Portfolio of Antimalarial Medicines, 2QResearch Development Translational Preclinical Preclinical Lead optimisation Phase I Human volunteers Phase IIa Patient exploratory Access Phase IIb/III Registration Patient confirmatory Under review * Oxaboroles 1 Project P218 MMV048 OZ439/PQP Tafenoquine Rectal Artesunate Anacor Novartis BIOTEC UCT/TIA Sanofi GSK CIPLA/Strides/TDR DHODH 3 Projects SJ733 ACT840 OZ439/FQ UTSW/UW/Monash GSK St Jude/Eisai Actelion Sanofi Open Source Drug Discovery Sydney Orthologue Leads Sanofi DDD498 Merck Serono (Dundee) Amino-alcohols Tetraoxanes PA92 Merck Serono LSTM/Liverpool (Drexel/UW/GNF) Imidazolidinediones WRAIR dUTPase inhibitors Medivir Pf.